Health
Newly identified biomarker could predict response to immune checkpoint inhibitors – News-Medical.net
A team of Roswell Park Comprehensive Cancer Center researchers has identified a new biomarker that could predict response to immune checkpoint inhibitors (ICI)…
A team of Roswell Park Comprehensive Cancer Center researchers has identified a new biomarker that could predict response to immune checkpoint inhibitors (ICI) shortly after patients with non-small cell lung cancer (NSCLC) initiate therapy. This discovery, published today in the journal Nature Communications, is not only an important step forward in lung cancer treatment, but also has implications for other malignancies, according to lead author Fumito Ito, MD, PhD, FACS.
“Although ICIs revolutionized…
-
Business24 hours agoThese 4 ASX mining stocks are rocketing as the rare earths boom intensifies
-
General21 hours agoBunbury man Stanley J Clemons sentenced for shooting neighbour’s dog
-
Noosa News24 hours agoLung cancer researchers identify ‘breakthrough’ patterns predictive of treatment success
-
Noosa News12 hours agoWarm weather could make way for rain with ‘damaging winds, large hail’